An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease
Status:
Completed
Trial end date:
2018-09-28
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the efficacy and safety of Sodium
Oligo-mannurarate (GV-971) in 36-week treatment of mild to moderate Alzheimer's disease.